-

12:02:39 PM

ANIK Stock News

ANIK - Anika Therapeutics Inc.

05/20/22 7:00 AM

Nasdaq : ANIK

low float

Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on

RHEA-AI

very positive

05/13/22 5:00 PM

Nasdaq : ANIK

low float

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 2, 2022, Anika granted non-statutory stock options (“Options”) covering an aggregate of 13,091 shares of

RHEA-AI

very positive

05/09/22 4:05 PM

Nasdaq : ANIK

conferenceslow float

Anika to Participate in the UBS Global Healthcare Conference 2022

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the UBS Global Healthcare Conference 2022 being held in-person at the Lotte New York

RHEA-AI

neutral

05/05/22 4:05 PM

Nasdaq : ANIK

earningslow float

Anika Reports First Quarter Fiscal 2022 Financial Results

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial

RHEA-AI

neutral

04/15/22 5:00 PM

Nasdaq : ANIK

low float

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on April 1, 2022, Anika granted non-statutory stock options covering an aggregate of 10,662 shares of common

RHEA-AI

very positive

04/07/22 4:05 PM

Nasdaq : ANIK

earningslow float

Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2022 financial results after the close of the market on Thursday,

RHEA-AI

neutral

04/04/22 4:05 PM

Nasdaq : ANIK

conferenceslow float

Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022.

RHEA-AI

neutral

03/23/22 8:30 AM

Nasdaq : ANIK

low float

Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual Meeting

Anika Therapeutics,

RHEA-AI

positive

03/15/22 7:00 PM

Nasdaq : ANIK

low float

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it granted: on March 1, 2022 to three newly hired non-executive employees, (a) non-statutory stock options

RHEA-AI

very positive

03/10/22 4:05 PM

Nasdaq : ANIK

conferenceslow float

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate at the Canaccord Genuity Musculoskeletal Conference in Chicago, IL on Tuesday, March

RHEA-AI

neutral

ANIK Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.anikatherapeutics.com
CeoJoseph Darling
Security nameAnika Therapeutics Inc.
Issue typecs
SectorManufacturing
Sic code3841
Employees277
Tags
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address32 Wiggins Ave
StateMassachusetts
CityBedford
Zip01730-2315
CountryUS
Phone17814579000

About Anika Therapeutics Inc.

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Anika Therapeutics partners with clinicians to understand what they need most to treat their patients and develos minimally invasive products that restore active living for people around the world. The company ise committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe.